Telemedicine in the treatment of gestational diabetes: an observational cohort study on pregnancy outcomes and maternal satisfaction
Montori S, Lugli F, Monesi M, et al.
Diabet Med. 2023;e15201.
Leggi
Breaking news
Cardiovascular efficacy and safety of antidiabetic agents: a network meta‐analysis of randomized controlled trials
Sohn M, Frias JP, Lim S
Diabetes Obes Metab. Pub. online 30 Aug 2023.
Leggi
A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States
Lin Y, Shao H, Fonseca V, et al.
Diabetes Obes Metab. 2023;25(10):2862-2868.
Leggi
Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study
Zeng J, Gan S, Mi N, et al.
Diabetes Obes Metab. 2023;25(10):2878-2887.
Leggi
Trajectories of fasting glucose and glycated haemoglobin in obese and non-obese incident diabetes: Results from two large cohort studies
Yu HJ, Ho M, Chau PH, Fong DYT
Diabetes Obes Metab. 2023;25(10):2835-2845.
Leggi
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing
Hughes AE, Houghton JAL, Bunce B, et al.
Diabetologia. Pub. online 31 Aug 2023.
Leggi
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes
Meek CL, Stewart ZA, Feig DS, et al.
Diabetologia. Pub. online 24 Aug 2023.
Leggi
Dapagliflozin in patients with heart failure and deterioration in estimate glomerular filtration rate to <25ml/min/1.73m2
Chatur S, Vaduganathan M, Claggett BL, et al.
J Am Coll Cardiol. 2023;S0735-1097(23)06532-4.
Leggi
Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 – a pilot study
Gravda K, Kirste KH, Grzelak K, et al.
BMC Endocr Disord. 2023;23(1):179.
Leggi
Efficacy of dapagliflozin according to geographic location of patients with heart failure
Kondo T, Wang X, Yang M, et al.
J Am Coll Cardiol. 2023;82(10):1014–1026.
Leggi